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ABSTRACT Background and aims: Data on the
useof antipsychoticsamongolder people in needof
regularhomecareservicesare rare. The aim of this
study wasto ascertainthedifferencesin the useand
typeof antipsychoticmedicationsbetweenEuropean
home-caresites. Methods: A cross-sectionalstudy
wasdesignedby meansof RAI (ResidentAssessment
Instrumentfor Home CareYassessments.A random
sampleof 3215 assessmentswasgatheredduringthe
period September2001-January 2002 from home
care patients aged 65 and over in nine European
countries(Czech Republic, Denmark, Finland, Ger-
many,Jceland,ltaly,Netherlands,Norwayand United
Kingdom).Results: Two hundredof thehomecarepa-
tients(6.2%)receivedantipsychoticmedication.The
prevalenceof the useof one or more antipsychotics
variedwidelybetweenstudysites,rangingfrom 3.0%
in Denmark to 12.4% in Finland. Factors indepen-
dentlyassociatedwith the useof antipsychoticswere:
delusions(OR 3.09, 95% CI 1.66-5.76),anydiagnosis
of dementia(OR 2.57, 95% CI 1.70-3.87),youngest
agegroup(65-74yrs)(OR 2.37, 95% CI 1.53-3.66)and
hallucinations (OR 2.28, 95% CI 1.17-4.45). Con-
comitantuseof anxiolytics(OR 2.32, 95% CI1.58-
3.41), hypnotics(OR 2.08, 95% CI 1.44-3.03)and
antidepressants(OR 2.06, 95% CI 1.41-3.00)togeth-
er with signsof depression(OR 1.78, 95% CI 1.24-
2.56), moderateto severecognitiveimpairment(OR
1.30,95% CI 1.12-1.51)and residingin Finland (OR
2.52, 95% CI 1.21-5.24)or Italy (OR 2.15, 95% CI





triesstudied.Antipsychotic drug treatmentin older
home-carerecipientsseemsto be lesscommonthanin
residentsin long-terminstitutional care, and more
commonthanamongtheindependently-livingelderly.
(AgingClin Exp Res 2008; 20.' ###-###)
~2008,EditriceKurtis
INTRODUCTION




portedthat the point prevalenceof havingpsychotic
symptomsrangesfrom3.2% to 5.7% inelderlypeopleIiv-
ingin thecommunity(3,4) to 10%in theveryoldpop-
ulation(5)andupto 41% in patientswithAlzheimer'sdis-








home-dwellingelderlyvariesat 3-9% (12-16). Antipsy-
choticsareusedsixtimesmorecommonlyin demented
individualsthanin non-dementedsubjects(12, 14). As-
sociationsbetweenthe use of antipsychoticsand the
levelof cognitivefunctioningandtheactivitiesof dailyIiv-
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There hasbeen concernabout the useof antipsy-












The Aged in Home Care (AdHOC) Studywas de-
signedto compareoutcomesof differentmodelsof com-
munitycareby meansof a structuredcomparisonof
servicesanda comprehensivestandardizedassessmentin-
strument(24).The presentdatawerederivedfromAd-
HOC duringthe period 2001-2002 in 11 European
countries,from which informationfrom two countries
wereexcluded,dueto lackof dataon medicationor in-
consistentrecordingof antipsychotics.In addition,those








cies servinga certaingeographicalarea.This register
ledtothecreationofa cross-nationalpopulation-basedda-
ta-setcontaininginformationon 3251assessmentsof sub-






formlytrainedin how to usethequestionnairewiththe


















cognitiveskills,or if theyhadan impacton prognosis.T0
assessdepression,the DepressionRatingScale(DRS,











Apart from medicationsfor dizzinessand/or nausea,
andlithium,allmedicationswithanATC codeof N05A










chotomousvariablesand the t-testfor continuousvari-
ables,to identifycrudeassociationsfor antipsychotic
use.Statisticallysignificant(p<0.05)factorsaccording











The meanageof the individualsin the samplewas
82.2 years(±7.3)(range65-104)and74.4%werewom-
en.Sociodemographicandmainclinicalcharacteristicsof
the patientsand the useof antipsychoticsare listedin
Table1. The proportionof patientswho hadbeenpre-
scribedone or more antipsychoticswas 6.2% of the


















2 838 1 4 54
Sex Women
2 14 5 933 7
Men
8 2256




Documenteddiagnoses Strok with or withouthemiplegia
8 47 0
Any dementia
392 3 17<0. 1
Parkinso ism
19 1 1 7
psy hiatr cdiagnosis
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'x2-tests,eomparedwiththerestof population.§DRS.DepressionRatingScale:~3indicatesdepression.·CPS. CognitivePerformanceScale:0 nocognitiveim-
pairment,1-2mildeognitiveimpairment,3-6moderatetosevereognitiveimpairment.**ADL,Aelivitiesof DailylivingSeale:0 nodependenceonassistance
withdailyIiving.1-2milddegreeofdependenceonassistancewithdailyIiving,3-6mcxleratetoseveredegreeofdependenceonassistancewithdailyIiving.















65 to 74 years,useof anxiolytics,antidepressantsandhyp-





(from3 to 12%)in theuseof antipsychoticsamongelderly
home-carerecipientsamongthesamplescollectedfrom
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the variouscountries.In accordancewith the present
results,a highprevalenceof antipsychoticdrugusein the

















of dementia,approximatelyone outof two patientshad
somedegreeof cognitiveimpairment.This suggeststhat
manyof thesepatientshadnotbeencarefullydiagnosed.
































































































mentwas more common in the youngestage group
(65-74yrs).This mayconflictwith previousreportsin




















atypicalto conventionalntipsychoticuseis3:2 or 2:1 (8,
9, 35, 36),althoughthesereportscamefromstudieson
elderlyresidentsin long-terminstitutionalcare. Varia-





therewereno specialrestrictionson prescriptionor re-
imbursementpoliciesregardingatypicalantipsychoticsin
Finlandbutin Jtalyreimbursementcanbeobtainedonly









thestudy.AlthoughtheMDS-HC is a standardized,com-
prehensiveassessmentinstrument,recordingof psychiatric





nor were individualindicationsfor antipsychoticdrug














the nine Europeancountriesstudied.Jn general,an-
tipsychoticdrugtreatmentin thispopulationseemsto be
less commonthan in residentsin long-termresidential
care,and is approximatelyas commonas in the inde-
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